Reports, Position Papers, Consensus Documents and Guidelines on Cardio-Oncology
2023
2022
2021
2020
- Routine cardiotoxicity echo screening for chemotherapy patients during COVID-19
- Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
- Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology
- The cancer patient and cardiology
- Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management
2019
2018
- Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council
- Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge
2016
2015
2014
- Multimodality imaging evaluation of adult patients during and after cancer therapy
- Cardiovascular side effects of cancer therapies
Survey
2018/2019
Survey on the Cardiology Care delivered to Cancer Patients, in collaboration with the Council for Cardiology Practice.
Our mission: To reduce the burden of cardiovascular disease.